How many insider trades does FilingIQ track for FATE?

FilingIQ tracks 557 Form 4 insider transactions for FATE (FATE THERAPEUTICS INC), covering filings from Jan 7, 2015 onwards. 2 of those are dated within the last 90 days.

Are FATE insiders net buyers or net sellers?

Across the full Form 4 history for FATE, 14 transactions (3%) were open-market purchases and 364 (65%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FATE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is FATE in?

FATE THERAPEUTICS INC (FATE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $178.81M.

FATE insider trading

NasdaqGM Healthcare

FATE THERAPEUTICS INC: insider trade history from SEC Form 4 filings.

Total Form 4 trades

557

Last 90 days

Buys / sells

3% / 65%

Market cap

$178.81M

About FATE THERAPEUTICS INC

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Company website: www.fatetherapeutics.com

FATE insider activity at a glance

FilingIQ tracks 557 insider transactions for FATE in filings since Jan 7, 2015. The most recent transaction is dated Aug 4, 2026.

Across the full history, 14 open-market purchases and 364 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FATE insider trades is 46.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FATE trades on FilingIQ Raw filings on SEC EDGAR

Latest FATE Form 4 filings

TAHL CINDY See Remarks

S Aug 5, 2026

Valamehr Bahram President and CEO

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for FATE?: FilingIQ tracks 557 Form 4 insider transactions for FATE (FATE THERAPEUTICS INC), covering filings from Jan 7, 2015 onwards. 2 of those are dated within the last 90 days.
Are FATE insiders net buyers or net sellers?: Across the full Form 4 history for FATE, 14 transactions (3%) were open-market purchases and 364 (65%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FATE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is FATE in?: FATE THERAPEUTICS INC (FATE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $178.81M.

Methodology & sources

Every FATE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.